COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma A/S exercises its authorization granted by its extraordinary general meeting held on July 31, 2017

09/08/2017 - 00:11

Company announcement - No. 30/2017 Zealand Pharma A/S exercises its authorization granted by its extraordinary general meeting held on July 31, 2017 in connection with its initial public offering of American Depositary [...]

Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update

08/08/2017 - 22:05

Net cash used in operating and investing activities was $36.3 million in the second quarter and $76.5 million for the first six months of 2017; quarter-end cash and restricted cash position of $475.8 million, provides [...]

Novavax Reports Second Quarter 2017 Financial Results

08/08/2017 - 22:05

GAITHERSBURG, Md., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2017. Second Quarter and Subsequent [...]

Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus®

08/08/2017 - 21:31

Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus ® Paris, France - August 8, 2017 - Sanofi announced today that it filed a patent infringement suit against Merck Sharp & Dohme Corp. ("Merck") on [...]

Sanofi intente une action en justice aux Etats-Unis pour défendre les brevets de Lantus®

08/08/2017 - 21:31

Sanofi intente une action en justice aux Etats-Unis pour défendre les brevets de Lantus ® Paris, France - Le 8 août 2017 - Sanofi annonce aujourd'hui avoir intenté le 8 août 2017 une action en contrefaçon contre Merck [...]

Ossur Hf : Transactions in relation to share buyback program

08/08/2017 - 18:00

A nnouncement from Össur hf. No. 55/2017 Reykjavík, 8 August 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is [...]

Novo Nordisk A/S - Share repurchase programme

08/08/2017 - 14:29

Bagsværd, Denmark, 8 August 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

iTeos Therapeutics SA: iTeos Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference

08/08/2017 - 14:00

iTeos Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference Gosselies, Belgium - August 8, 2017 - iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

08/08/2017 - 13:00

FIT Biotech Oy Company release August 8, 2017 at 02:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

uniQure Announces Second Quarter 2017 Financial Results and Recent Company Progress

08/08/2017 - 13:00

~ Advancing Gene Therapy Programs in Hemophilia B and Huntington's Disease ~ ~ Provides Update on Research Collaboration with Bristol-Myers Squibb ~ ~ Makes New Appointments to Company Leadership and Nominations to [...]

Verona Pharma plc Interim Results for the Six Months Ended June 30, 2017 and Clinical Development Update

08/08/2017 - 08:00

Completed US IPO Continues to advance lead candidate RPL554 with four clinical trials commenced LONDON, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma" or the "Company"), a [...]

Communiqué de presse relatif à la solution ophtalmique de latanoprostène bunod, 0,024%

08/08/2017 - 07:30

Communiqué de presse Communiqué de presse relatif à la solution ophtalmique de latanoprostène bunod, 0,024% 8 août 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX, éligible PEA-PME), société [...]

Press Release concerning latanoprostene bunod ophthalmic solution, 0.024%

08/08/2017 - 07:30

Press Release Press Release concerning latanoprostene bunod ophthalmic solution, 0.024% 8 August 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company [...]

argenx to Present at Wedbush PacGrow Healthcare Conference

08/08/2017 - 07:00

Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]

MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group

08/08/2017 - 07:00

COMPANY ANNOUNCEMENT / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, August 8, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced it has signed a health care services [...]

MDxHealth annonce un contrat de service avec Kaiser Southern California Permanente Medical Group

08/08/2017 - 07:00

Annonce d'entreprise / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CALIFORNIE et HERSTAL, BELGIQUE - 07:00 CEST, le 8 août, 2017 - MDxHealth SA (Euronext: MDXH.BR) a annoncé aujourd'hui la signature d'un [...]

INNATE PHARMA : Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 4 aout 2017

08/08/2017 - 07:00

nouveau NOMBRE D'ACTIONS ET DE DROITS DE VOTE d'InnatE Pharma AU 4 août 2017 Marseille, le 8 août 2017, 7h00 CEST Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l'Autorité [...]

INNATE PHARMA : Number of shares and voting rights of Innate Pharma as at August 4, 2017

08/08/2017 - 07:00

NUMBER OF SHARES AND VOTING RIGHTS OF Innate Pharma AS AT AUGUST 4, 2017 Marseille, France, AUGUST 8, 2017, 7:00 AM CEST Pursuant to the article L. 233-8 II of the French « Code de Commerce » and the article 223-16 of [...]

VIFOR PHARMA REPORTS STRONG H1 2017 RESULTS AND RAISES GUIDANCE

08/08/2017 - 06:55

PRESSEMITTEILUNG PRESS RELEASE COMMUNIQUÉ DE PRESSE This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that [...]